Fonar Corp(FONR) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | - | P/E | 19.15 | EPS (ttm) | 1 | Insider Own | 21.99% | Shs Outstand | 6.2M | Perf Week | - |
| Market Cap | 0.12B | Forward P/E | - | EPS next Y | - | Insider Trans | 67.01% | Shs Float | 4.9M | Perf Month | 1.22% |
| Enterprise Value | 0.09B | PEG | - | EPS next Q | - | Inst Own | 46.91% | Short Float | 0.97% | Perf Quarter | 3.58% |
| Income | 0.01B | P/S | 1.14 | EPS this Y | - | Inst Trans | - | Short Ratio | 0.59 | Perf Half Y | 33.96% |
| Sales | 0.11B | P/B | 0.67 | EPS next 5Y | - | ROA | 3.08% | Short Interest | 0.05M | Perf YTD | 2.86% |
| Book/sh | 28.46 | P/C | 2.23 | EPS past 3/5Y | -11.05% 0.9% | ROE | 3.82% | 52W High | -0.34% ($19.16) | Perf Year | 31.66% |
| Cash/sh | 8.56 | P/FCF | 25.67 | Sales past 3/5Y | 2.26% 4.02% | ROIC | 3.14% | 52W Low | 40.16% ($13.62) | Perf 3Y | 13.43% |
| Dividend Est. | - | EV/EBITDA | 6.42 | EPS Y/Y TTM | -19.05% | Gross Margin | 40.26% | Volatility(W/M) | 0.43% 0.26% | Perf 5Y | 5.82% |
| Dividend TTM | - | EV/Sales | 0.86 | Sales Y/Y TTM | 2.25% | Oper. Margin | 9.05% | ATR (14) | 0.05 | Perf 10Y | 16.12% |
| Dividend Ex-Date | - | Quick Ratio | 9 | EPS Q/Q | -34.52% | Profit Margin | 6.05% | RSI (14) | 75.02 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 9.18 | Sales Q/Q | -2.55% | SMA20 | 0.86% ($18.93) | Beta | 0.95 | Target Price | - |
| Payout | - | Debt/Eq | 0.22 | Earnings | - | SMA50 | 1.57% ($18.79) | Rel Volume | 0 | Prev Close | $19.09 |
| Employees | 535 | LT Debt/Eq | 0.19 | EPS/Sales Surpr. | - | SMA200 | 12.29% ($17) | Avg Volume(3M) | 0.08M | Price | $19.09 |
| IPO | 1981/10/23 | Option/Short | No/No | Trades | 0 | Volume | - | Change | - |
Company
FONR is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
A specialized medical device company that developed the world's first commercial MRI, holding a unique Stand-Up MRI technology. The company generates stable revenue through the manufacturing of innovative diagnostic equipment that allows patients to be scanned while seated or standing, as well as through the operation of large-scale imaging diagnostic center management services.
Over the past 1 year, on the higher side
0% below its 1-year high.
FONR makes money exceptionally well
Strong earnings and excellent financial health
Tap to view numbers
The stock looks undervalued
Trading at 19.1 times earnings.
Tap to view numbers
Holding long would have paid off
Would have changed by +13.4% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 46.9%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
DEEP 0.01%
IWC 0.00%
AVUV 0.00%
DFAS 0.00%
DFAT 0.00%It ranks #4 in the industry
Based on market cap of $120M.
FONR $120M PER 19.1
TMO $225B PER 32.8
DHR $141B PER 35.5
NTRA $47B PER -
FAQ
What kind of company is FONR?
FONR belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is the market cap of FONR?
The market cap of FONR is approximately $120M, ranking 4,452 within its sector.
What is the P/E ratio of FONR?
FONR has a P/E ratio of approximately 19.1x, which can be used to assess its valuation relative to the Healthcare sector average.
What is the 52-week high and low for FONR?
FONR has recorded a 52-week high of $19.16 and a low of $13.62.
